STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice.

Florence Meyer-losic, Simon P. Newman, Joanna M. Day, Michael J. Reed, Philip G. Kasprzyk, Atul Purohit, Paul A. Foster, Ming Tan (Editor)

    Research output: Contribution to journalArticlepeer-review

    17 Citations (Scopus)
    288 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice.'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Agriculture & Biology

    Chemistry